Valuation : Guided Therapeutics Inc

Market Cap 22.4M 19.34M 18.12M 16.55M 31.15M 2.14B 31.29M 215M 83.91M 1.08B 84.08M 82.25M 3.59B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 25.27M 21.83M 20.45M 18.68M 35.15M 2.41B 35.31M 242M 94.68M 1.22B 94.88M 92.81M 4.05B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 05/03/2023
Chief Tech/Sci/R&D Officer 70 01/12/2010
Director TitleAgeSince
Director/Board Member 70 30/11/2016
Director/Board Member 76 09/04/2006
Chairman 67 30/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%-1.13%+26.27%+12.02% 230B
+0.18%-1.27%+4.98%-18.16% 152B
+1.51%-1.64%-21.28%+20.04% 132B
+0.36%-7.01%-55.60%-14.34% 67.88B
+0.29%+0.47%+10.90%+15.91% 52B
+0.66%-1.69%-16.47%-14.35% 51.05B
-2.44%-3.25%+22.43%+26.08% 43.38B
-1.56%+0.97%+37.41%+44.08% 40.74B
+1.94%+3.81%-12.45%+46.61% 34.67B
Average -0.05%-0.84%-0.42%+13.10% 89.25B
Weighted average by Cap. -0.14%-1.29%+2.51%+7.86%

Financials

2024 2025
Net sales 7K 6.05K 5.66K 5.17K 9.74K 668K 9.78K 67.14K 26.22K 338K 26.28K 25.71K 1.12M 767K 662K 621K 567K 1.07M 73.14M 1.07M 7.36M 2.87M 37M 2.88M 2.82M 123M
Net income -2.42M -2.09M -1.96M -1.79M -3.36M -230M -3.38M -23.18M -9.06M -117M -9.07M -8.88M -387M -3.2M -2.76M -2.59M -2.36M -4.45M -305M -4.47M -30.66M -11.97M -154M -12M -11.74M -512M
Net Debt 1.77M 1.53M 1.43M 1.31M 2.46M 169M 2.47M 16.99M 6.63M 85.44M 6.65M 6.5M 284M 2.88M 2.48M 2.33M 2.13M 4M 274M 4.02M 27.59M 10.77M 139M 10.8M 10.56M 461M
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-